PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial - Kreissl, S; Goergen, H; Buehnen, I (Lancet Haematol, 2021)